Business Description

Tirzepatide (Tilpotide )(Mounjaro) is a novel glucose-dependent insulin-promoting polypeptide and glucagon-like peptide-1 receptor agonist, which can bind to albumin and prolong the half-life. Tilpotide can enhance the secretion of primary and secondary insulin and reduce the level of glucagon, both of which are glucose-dependent. It can reduce fasting and postprandial glucose concentrations in people with type 2 diabetes, reduce food intake, and lose weight.
Tilpotide can be used as an adjunctive to diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus

• Reviews & Ratings
• Write a Review